KMB

Business Context and Reporting Period

Company: Kimberly-Clark Corporation
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2004
Business Overview: A global health and hygiene company operating in three segments: Personal Care (diapers, feminine care), Consumer Tissue (facial/bathroom tissue), and Business-to-Business (professional health and hygiene products).
Key Event: On November 30, 2004, the company completed the spin-off of Neenah Paper, Inc., distributing all shares to stockholders. Neenah Paper's fine and technical paper businesses are reported as discontinued operations.

Key Financial Metrics (2004)

Material Changes vs. Prior Period

• Sales Growth: Net sales increased 7.5% year-over-year, driven by a 5% volume increase and favorable currency effects (approx. 3%), partially offset by lower net selling prices.
• Profitability: Operating profit rose 7.5% to $2.5 billion. Cost savings of nearly $160 million helped offset over $180 million in higher costs for fiber, materials, energy, and distribution.
• Segment Performance:
  • Personal Care: Sales up 5.7%; Operating profit up 2.6% despite competitive pricing pressures and a $37 million charge for a diaper manufacturing streamlining plan.
  • Consumer Tissue: Sales up 5.9%; Operating profit up 10.3% driven by cost savings and favorable currency, offset by higher fiber costs.
  • Business-to-Business: Sales up 13.8%; Operating profit up 8.9% due to volume growth in health care and professional products.
• Shareholder Returns: The company repurchased 24.8 million shares for approximately $1.6 billion. Annual cash dividends increased 17.6% to $1.60 per share.
• Discontinued Operations: Income from discontinued operations (Neenah Paper) was $29.8 million in 2004, down from $50.6 million in 2003, due to transaction costs and a shorter reporting period.

Guidance, Outlook, and Risks

2005 Outlook

• Sales Growth: Targeted at 3% to 5%, driven primarily by volume improvements.
• Earnings: Expected diluted earnings per share of $3.70 to $3.85 (mid-to-high single-digit growth).
• Cost Savings: Targeting $150 million in cost savings to improve operating margins by up to 20 basis points.
• Capital Allocation: Capital spending estimated at $800 million; share repurchases targeted at at least $1 billion; dividends increased 12.5% effective April 2005.

Risks and Contingencies

• Raw Materials: Significant exposure to pulp and petroleum-based material price fluctuations. The Neenah Paper spin-off reduced internal pulp supply from 40% to 10%, increasing commodity price risk.
• Competition: Intense competition in North America and Europe, particularly in diapers and tissue, leading to pricing pressure and increased promotional spending.
• Foreign Currency: A 10% unfavorable change in exchange rates could result in a $43 million pretax loss on transactional exposures and a $638 million reduction in stockholders' equity due to translation adjustments.
• Legal/Environmental: Ongoing asbestos litigation (claims tendered to insurance) and environmental remediation obligations. Management does not expect these to have a material adverse effect.
• Pension Obligations: Defined benefit plans are underfunded by approximately $1.2 billion (PBO exceeds assets). Pension expense is estimated at $160 million for 2005.

Investor Verification Checklist

• Neenah Paper Spin-off Impact: Verify the long-term pulp supply agreement terms with Neenah Paper and the resulting exposure to external pulp price volatility.
• Cost Savings Realization: Monitor the achievement of the targeted $150 million in 2005 cost savings against rising input costs (fiber, energy).
• Competitive Pricing: Assess the sustainability of volume growth in the face of aggressive competitor pricing in the diaper and tissue categories.
• Pension Funding: Review future cash requirements for pension contributions, given the $1.2 billion underfunding status and sensitivity to discount rate changes.
• Share Repurchase Execution: Confirm the execution of the targeted $1 billion in share repurchases for 2005.